Protein kinase C beta isoenzymes in diabetic kidneys and their relation to nephroprotective actions of the ACE inhibitor lisinopril

Kidney and Blood Pressure Research

Volumn 25, Issue 5, 2002, Pages 329-340

  Pfaff, Imke L ^a   Vallon, Volker ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

ACE inhibitor; Diabetic nephropathy; Interstitial cells; Kidney; Protein kinase C beta; Proximal tubule

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOENZYME; LISINOPRIL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN KINASE C BETA; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANIMAL; CELL PROTECTION; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; IN VITRO STUDY; KIDNEY; METABOLISM; SPRAGUE DAWLEY RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; KIDNEY; LISINOPRIL; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036435488     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066789     Document Type: Article

References (43)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998;9:1213-1224.
3. Abbate M, Remuzzi G: Proteinuria as a mediator of tubulointerstitial injury. Kidney Blood Press Res 1999;22:37-46.
4. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143-1155.
5. Bohle A, Mackensen-Haen S, von Gise H, Grund KE, Wehrmann M, Batz C, Bogenschütz O, Schmitt H, Nagy J, Müller C, et al: The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990;186:135-144.
6. D'Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial damage in glomerular diseases: Its role in the progression of renal damage. Am J Kidney Dis 1995;26:124-132.
7. Eddy AA, Schnaper HW: The nephrotic syndrome: From the simple to the complex. Semin Nephrol 1998;18:304-316.
8. Zoja C, Benigni A, Remuzzi G: Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators. Exp Nephrol 1999;7:420-428.
9. Wang SN, LaPage J, Hirschberg R: Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 2000;57:1002-1014.
10. Wang SN, Lapage J, Hirschberg R: Glomerular ultrafiltration and apical tubular action of IGF-I, TGF-beta, and HGF in nephrotic syndrome. Kidney Int 1999;56:1247-1251.
11. Sassy-Prigent C, Heudes D, Mandet C, Belair MF, Michel O, Perdereau B, Bariety J, Bruneval P: Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000;49:466-475.
12. Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K, Yoshinaga K: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 1993;21:480-485.
13. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL: Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 1997;100:115-126.
14. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992;89:11059-11063.
15. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996;272:728-731.
16. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 2000;14:439-447.
17. Studer RK, Negrete H, Craven PA, De Rubertis FR: Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-beta bioactivity in mesangial cells. Kidney Int 1995:48:422-430.
18. Pfaff IL, Wagner HJ, Vallon V: Immunolocalization of protein kinase C isoenzymes alpha, beta I and beta II in rat kidney. J Am Soc Nephrol 1999;10:1861-1873.
19. Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G: Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents slate renal structural damage. Exp Nephrol 1994;2:220-228.
20. Viberti G, Mogensen CE, Groop LC, Pauls JF, European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275-279.
21. Morano S, D'Erme M, Sensi M, De Rossi MG, Medici F, Galliccia F, Andreani D, Mi Mario U: Characteristics of proteinuria in experimental diabetes mellitus. Biochem Med Metab Biol 1994;53:92-97.
22. Whiteland JL, Nicholls SM, Shimeld C, Easty DL, Wiliams NA, Hill TJ: Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem 1995;43:313-320.
23. Krug E, Biemann HP, Tashjian AH: Evidence for increased synthesis as well as increased degradation of protein kinase C after treatment of human osteosarcoma cells with phorbol ester. J Biol Chem 1987;262:11852-11856.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
25. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage sub-populations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985;54:589-599.
26. Babazono T, Kapor-Drezgic J, Dlugosz JA, Whiteside C: Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 1998;47:668-676.
27. Kang N, Alexander G, Park JK, Maasch C, Buchwalow I, Luft FC, Haller H: Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int 1999;56:1737-1750.
28. Tucker BJ, Rasch R, Blantz RC: Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats. J Clin Invest 1993;92:686-694.
29. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993;90:1814-1818.
30. Murray NR, Davidson LA, Chapkin RS, Clay Gustafson W, Schattenberg DG, Fields AP: Overexpression of protein kinase C beta II induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J Cell Biol 1999;17:699-711.
31. Saxena R, Saksa BA, Hawkins KS, Ganz MB: Protein kinase C beta I and beta II are differentially expressed in the developing glomerulus. FASEB J 1994;8:646-653.
32. Ceolotto G, Gallo A, Miola M, Sartori M, Trevisan R, Del Prato S, Semplicini A, Avogaro A: Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes 1999;48:1316-1322.
33. Hise MK, Mehta PS: Characterization and localization of calcium/phospholipid-dependent protein kinase-C during diabetic renal growth. Endocrinology 1988;123:1553-1558.
34. Horie S, Moe O, Miller RT, Alpern RJ: Long-term activation of protein kinase C causes chronic Na/H antiporter stimulation in cultured proximal tubule cells. J Clin Invest 1992; 89:365-372.
35. (+)-ATP epsilon in rat proximal convoluted tubules. Am J Physiol 1995;268:C1277-C1283.
36. Singh H, Linas SL: Role of protein kinase C in beta 2-adrenoceptor function in cultured rat proximal tubule epithelial cells. Am J Physiol 1997;273:F193-F199.
37. + uptake induced by angiotensin II in primary cultured rabbit renal proximal tubule cells. J Vet Med Sci 1999;61:135-141.
38. +-ATPase activity. FEBS Lett 1999;30:45-48.
39. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H: Glomerular hyperfiltration in experimental diabetes mellitus: Potential role of tubular reabsorption. J Am Soc Nephrol 1999; 10:2569-2576.
40. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V: Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 2001;107:217-224.
41. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-1462.
42. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes. A meta-regression analysis. Ann Intern Med 1993;118:129-138.
43. Houillier P, Chambrey R, Achard JM, Frois-sart M, Poggioli J, Paillard M: Signaling pathways in the biphasic effect of angiotensin II on apical Na/H antiport activity in proximal tubule. Kidney Int 1996;50:1496-1505.